ksolanki | 3 years ago | on: Study Finds Another Condition That Vitamin D Pills Do Not Help
ksolanki's comments
ksolanki | 4 years ago | on: Can I Email?
That should work to each party’s satisfaction.
ksolanki | 5 years ago | on: Gitlab is moving to a three-tier product subscription model
ksolanki | 5 years ago | on: FTC Sues Facebook for Illegal Monopolization
I am sure people have thought about this.
All the Government needs to do is to enforce compliance to such standards.
ksolanki | 5 years ago | on: Raspberry Pi 400 Desktop PC
In any case, over the years I have become very comfortable using mouse with left hand as a right hander.
ksolanki | 5 years ago | on: California appeals court rules Uber, Lyft must reclassify drivers as employees
ksolanki | 5 years ago | on: Apple just kicked Fortnite off the App Store
ksolanki | 5 years ago | on: Bertrand Russell's argument for idleness is more relevant than ever
ksolanki | 6 years ago | on: Amazon to suspend delivery service that competes with UPS, FedEx
Every family will have a drone “pet” with sole purpose if delivering Amazon stuff, in this case literally.
ksolanki | 6 years ago | on: How SEO Ruined the Internet
Google or not, what can help me discover the right recipe, the right content, the right answer to my coding error?
Search algorithms that keep “mutating” even randomly? Ranking system? What?
ksolanki | 6 years ago | on: GM’s CEO Offers to Make Ventilators in WWII-Style Mobilization
ksolanki | 6 years ago | on: Ask HN: Who is hiring? (September 2019)
Join us in building software platform to apply deep learning and robotics to help prevent blindness across the world. Eyenuk is global medical technology company that has developed a powerful retinal image analysis AI eye screening platform for detection of diseases. Eyenuk is on a mission to screen every eye in the world to detect and monitor life- and vision-threatening diseases including diabetic retinopathy, macular degeneration, glaucoma, cardiovascular and stroke risk, and Alziemer's disease.
Eyenuk's first product, EyeArt, is a fully autonomous (no doctor oversight needed) AI eye screening system for detection of diabetic retinopathy. Anyone with diabetes is vulnerable to blindness that progresses without any pain or discomfort. Despite it's preventable nature, the condition, called diabetic retinopathy, is the leading cause of blindness in working age adults. Eyenuk has developed EyeArt, a SaaS offering, that automates the retinal disease screening process via automated analysis of retinal images and providing a screening referral outcome. EyeArt is a clinically validated on over 100,000 patients providing sensitivity that exceeds that of expert human graders. EyeArt has CE Marking (regulatory approval in Europe) and has completed prospective clinical trials for an FDA clearance. The results are exceptional: https://finance.yahoo.com/news/eyenuk-ai-eye-screening-syste....
You will join a passionate team at Eyenuk comprised of software and machine learning experts. We are hiring for multiple positions in the following two broad categories.
* Full-stack software engineers (Python, Frontend, UI)
* Algorithms engineer (machine learning, computer vision, deep learning)
jobs at eyenuk.com
ksolanki | 6 years ago | on: Ask HN: Who is hiring? (August 2019)
Join us in building software platform to apply deep learning and robotics to help prevent blindness across the world. Eyenuk is global medical technology company that has developed a powerful retinal image analysis AI eye screening platform for detection of diseases. Eyenuk is on a mission to screen every eye in the world to detect and monitor life- and vision-threatening diseases including diabetic retinopathy, macular degeneration, glaucoma, cardiovascular and stroke risk, and Alziemer's disease.
Eyenuk's first product, EyeArt, is for fully autonomous AI eye screening system for detection of diabetic retinopathy. Anyone with diabetes is vulnerable to blindness that progresses without any pain or discomfort. Despite it's preventable nature, the condition, called diabetic retinopathy, is the leading cause of blindness in working age adults. Eyenuk has developed EyeArt, a SaaS offering, that automates the retinal disease screening process via automated analysis of retinal images and providing a screening referral outcome. EyeArt is a clinically validated on over 100,000 patients providing sensitivity that exceeds that of expert human graders. EyeArt has CE Marking (regulatory approval in Europe) and has completed prospective clinical trials for an FDA clearance. The results are exceptional: https://finance.yahoo.com/news/eyenuk-ai-eye-screening-syste....
You will join a passionate team at Eyenuk comprised of software and machine learning experts. We are hiring for multiple positions in the following two broad categories.
* Full-stack software engineers (Python, Frontend, UI)
* Algorithms engineer (machine learning, computer vision, deep learning)
jobs at eyenuk.com
ksolanki | 6 years ago | on: Ask HN: Who is hiring? (June 2019)
Join us in building software platform to apply deep learning and robotics to help prevent blindness across the world. Eyenuk is global medical technology company that has developed a powerful retinal image analysis AI eye screening platform for detection of diseases. Eyenuk is on a mission to screen every eye in the world to detect and monitor life- and vision-threatening diseases including diabetic retinopathy, macular degeneration, glaucoma, cardiovascular and stroke risk, and Alziemer's disease.
Eyenuk's first product, EyeArt, is for fully autonomous AI eye screening for detection of diabetic retinopathy. Anyone with diabetes is vulnerable to blindness that progresses without any pain or discomfort. Despite it's preventable nature, the condition, called diabetic retinopathy, is the leading cause of blindness in working age adults. Eyenuk has developed EyeArt, a SaaS offering, that automates the retinal disease screening process via automated analysis of retinal images and providing a screening referral outcome. EyeArt is a clinically validated on over 100,000 patients providing sensitivity that exceeds that of expert human graders. EyeArt has CE Marking (regulatory approval in Europe) and has completed prospective clinical trials for an FDA clearance. The results are exceptional: https://finance.yahoo.com/news/eyenuk-ai-eye-screening-syste....
You will join a passionate team at Eyenuk comprised of software and machine learning experts. We are hiring for multiple positions in the following two broad categories.
* Full-stack software engineers (Python, Frontend, UI)
* Algorithms engineer (machine learning, computer vision, deep learning)
jobs at eyenuk.com
ksolanki | 6 years ago | on: YC's request for startups: Government 2.0
ksolanki | 6 years ago | on: Ask HN: Who is hiring? (May 2019)
Join us in building software platform to apply deep learning and robotics to help prevent blindness across the world. Eyenuk is global medical technology company that has developed a powerful retinal image analysis AI eye screening platform for detection of diseases. Eyenuk is on a mission to screen every eye in the world to detect and monitor life- and vision-threatening diseases including diabetic retinopathy, macular degeneration, glaucoma, cardiovascular and stroke risk, and Alziemer's disease.
Eyenuk's first product, EyeArt, is for fully autonomous AI eye screening for detection of diabetic retinopathy. Anyone with diabetes is vulnerable to blindness that progresses without any pain or discomfort. Despite it's preventable nature, the condition, called diabetic retinopathy, is the leading cause of blindness in working age adults. Eyenuk has developed EyeArt, a SaaS offering, that automates the retinal disease screening process via automated analysis of retinal images and providing a screening referral outcome. EyeArt is a clinically validated on over 100,000 patients providing sensitivity that exceeds that of expert human graders. EyeArt has CE Marking (regulatory approval in Europe) and has completed prospective clinical trials for an FDA clearance. The results are exceptional: https://finance.yahoo.com/news/eyenuk-ai-eye-screening-syste...
You will join a passionate team at Eyenuk comprised of software and machine learning experts. We are hiring for multiple positions in the following two broad categories.
* Full-stack software engineers (Python, Frontend, UI)
* Algorithms engineer (machine learning, computer vision, deep learning)
Would welcome anyone who wants to join our hands: have a young family? Great! Need a visa? We'll do everything legally possible to get you one.
jobs at eyenuk.com
ksolanki | 7 years ago | on: H-1B: Oracle favored hiring foreign graduates of US colleges over American grads
ksolanki | 7 years ago | on: Ask HN: Who is hiring? (January 2019)
Join us in building software platform to apply deep learning and robotics to help prevent blindness across the world. Eyenuk is global medical technology startup company that has developed a powerful retinal image analysis AI eye screening platform for detection of diseases. Eyenuk is on a mission to screen every eye in the world to detect and monitor life- and vision-threatening diseases including diabetic retinopathy, macular degeneration, glaucoma, cardiovascular and stroke risk, and Alziemer's disease.
Eyenuk's first product, EyeArt, is for fully autonomous AI eye screening for detection of diabetic retinopathy. Anyone with diabetes is vulnerable to blindness that progresses without any pain or discomfort. Despite it's preventable nature, the condition, called diabetic retinopathy, is the leading cause of blindness in working age adults. Eyenuk has developed EyeArt, a SaaS offering, that automates the retinal disease screening process via automated analysis of retinal images and providing a screening referral outcome. EyeArt is a clinically validated on over 100,000 patients providing sensitivity that exceeds that of expert human graders. EyeArt has CE Marking (regulatory approval in Europe) and has completed prospective clinical trials for an FDA clearance.
You will join a passionate team at Eyenuk comprised of software and machine learning experts. We are hiring for multiple positions in the following two broad categories.
* Full-stack software engineers (Python, Frontend, UI)
* Algorithms engineer (machine learning, computer vision, deep learning)
Would welcome anyone who wants to join our hands: have a young family? Great! Need a visa? We'll do everything legally possible to get you one.
jobs at eyenuk.com
ksolanki | 7 years ago | on: GitLab Made $10.5M in Revenue with Every Employee Working from Home
ksolanki | 7 years ago | on: Power Worth Less Than Zero Spreads as Green Energy Floods the Grid
This will encourage market for devices that can utilize the lower spot prices dynamically and keep the things more efficient overall (in steady state).
"So, for the millions of Americans who take vitamin D supplements and the labs that do more than 10 million vitamin D tests each year, an editorial published along with the paper has some advice: Stop.
“Providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements and people should stop taking vitamin D supplements in order to prevent major diseases or extend life,” wrote Dr. Steven R. Cummings, a research scientist at the California Pacific Medical Center Research Institute, and Dr. Clifford Rosen, a senior scientist at the Maine Medical Research Institute. Dr. Rosen is an editor at The New England Journal of Medicine."